|
시장보고서
상품코드
1741369
백신 기술 시장 : 기술별, 적응 질환별, 투여 경로별, 연령층별, 유통 채널별, 지역별Vaccine Technologies Market, By Technology, By Disease Indication, By Route of Administration, By Age Group, By Distribution Channel, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
백신 기술 시장은 2025년에는 554억 4,000만 달러로 추정되고, 2032년에는 1,115억 2,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 10.5%를 나타낼 전망입니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 554억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간(2025-2032년) CAGR | 10.50% | 가치 예측(2032년) | 1,115억 2,000만 달러 |
백신 기술은 백신을 만드는 데 사용되는 방법과 전략을 말합니다. 백신은 특정 질병에 대한 면역력을 향상시키는 생물학적 물질입니다. 이 혁신적인 방법은 mRNA, 바이러스 벡터, 단백질 서브 유닛, DNA 기반 플랫폼 등 다양한 접근법을 이용하고 있습니다. 첨단기술은 신속한 개발과 새로운 병원체에의 적응을 가능하게 합니다. 면역계를 자극하여 특정 질병을 인식하고 싸우게 함으로써, 이러한 백신은 세계의 건강과제에 의해 효과적으로 임하기 위한 유망한 수단을 제공합니다. 적극적이고 정확한 질병 관리의 새로운 시대가 도래했습니다.
시장 역학 :
규제 당국에 의한 제품 허가 증가는 예측 기간에 있어서 세계의 백신 기술 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2022년 12월 다국적 제약회사인 다케다제약은 유럽위원회(EC)가 유럽연합(EU)에서 4세 이상의 뎅기열 예방을 위한 자사의 뎅기열 백신 큐덴가(뎅기열 4가 백신[생백신, 약독화])(TAK-003)에 대해 판매 허가를 부여했다고 발표했습니다. 또한 2021년 6월에는 바이오 제약 회사인 캔시노바이오가 중국 국가약품감독관리국(NMPA)으로부터 멘페시아라는 상품명을 가진 그룹 C 및 그룹 A 수막구균 접합 백신에 대한 승인을 받았다고 발표했습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 백신 기술 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간 2025-2032년 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
- 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터를 바탕으로 백신 기술 시장 주요 기업 프로파일을 제공합니다.
- 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 백신 기술 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자들은 백신 기술 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 세계의 건강 문제와 유행
- 성장 억제요인
- 규제상의 과제
- 기회
- 주요 시장 기업 간 라이선스 계약 증가
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER's 분석
- 합병과 인수 시나리오
제4장 세계의 백신 기술 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 백신 기술 시장, 기술별(2020-2032년)
- 생약독화 백신
- 불활화 백신
- 서브 유닛 백신
- 톡소이드 백신
- 바이러스 벡터 백신
- 메신저 RNA(mRNA) 백신
제6장 세계의 백신 기술 시장, 적응 질환별(2020-2032년)
- 감염증 질환
- 비감염성 질환
제7장 세계의 백신 기술 시장, 투여 경로별(2020-2032년)
- 비경구
- 경구
- 비강
제8장 세계의 백신 기술 시장, 연령층별(2020-2032년)
- 소아
- 성인
제9장 세계의 백신 기술 시장, 유통 채널별(2020-2032년)
- 공공 부문
- 민간 부문
제10장 세계의 백신 기술 시장, 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙 아프리카
- 남아프리카
제11장 경쟁 구도
- Pfizer-BioNTech
- Moderna
- Johnson & Johnson
- AstraZeneca
- Sanofi
- Novavax
- GSK
- Sinovac Biotech
- Bharat Biotech
- Emergent BioSolutions
- Dynavax Technologies
- CureVac
- Valneva
- Takeda Pharmaceutical Company Limited
제12장 섹션
- 조사 방법
- 출판사에 대해
Vaccine Technologies Market is estimated to be valued at USD 55.44 Bn in 2025 and is expected to reach USD 111.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 55.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.50% | 2032 Value Projection: | USD 111.52 Bn |
Vaccine technology refers to the methods and strategies used to create vaccines. Vaccines are biological substances that can improve immunity to a particular disease. They prepare the body's immune system to fight off specific infections. Vaccine technologies have witnessed remarkable advancements, revolutionizing disease prevention. These innovative methods utilize various approaches such as mRNA, viral vector, protein subunit, and DNA-based platforms. Unlike traditional vaccines, these cutting-edge technologies enable rapid development and adaption to emerging pathogens. By stimulating the immune system to recognize and combat specific diseases, these vaccines offer promising avenues to tackle global health challenges more effectively. As a result, the landscape of immunization has evolved, ushering in a new era of proactive and precise disease control. Vaccine technologies includes live-attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, viral vector vaccines, messenger rna (mrna) vaccines.
Market Dynamics:
Increasing product approval by the regulatory authorities is expected to drive the growth of the global vaccine technologies market over the forecast period. For instance, in December 2022, Takeda Pharmaceutical Company Limited, a multinational pharmaceutical company, announced that the European Commission (EC) had granted marketing authorization for the company's dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in individuals from four years of age in the European Union (EU). Moreover, in June 2021, CanSinoBIO, a biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has the trade name Menphecia. Menphecia delivers protection against infection with Group A and C Neisseria meningitides.
Key features of the study:
- This report provides an in-depth analysis of the global vaccine technologies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the vaccine technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Sanofi, Novavax, GSK, Sinovac Biotech, Bharat Biotech, Emergent BioSolutions, Dynavax Technologies, CureVac, Valneva, and Takeda Pharmaceutical Company Limited.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global vaccine technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vaccine technologies market
Detailed Segmentation:
- Global Vaccine Technologies Market, By Technology:
- Live-attenuated vaccines
- Inactivated vaccines
- Subunit vaccines
- Toxoid vaccines
- Viral vector vaccines
- Messenger RNA (mRNA) vaccines
- Global Vaccine Technologies Market, By Disease Indication:
- Infectious Diseases
- Non-Infectious Diseases
- Global Vaccine Technologies Market, By Route of Administration:
- Parenteral
- Oral
- Nasal
- Global Vaccine Technologies Market, By Age Group:
- Pediatric
- Adult
- Global Vaccine Technologies Market, By Distribution Channel:
- Public Sector
- Private Sector
- Global Vaccine Technologies Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profile:
- Pfizer-BioNTech
- Moderna
- Johnson & Johnson
- AstraZeneca
- Sanofi
- Novavax
- GSK
- Sinovac Biotech
- Bharat Biotech
- Emergent BioSolutions
- Dynavax Technologies
- CureVac
- Valneva
- Takeda Pharmaceutical Company Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Vaccine Technologies, By Technology
- Market Vaccine Technologies, By Disease Indication
- Market Vaccine Technologies, By Route of Administration
- Market Vaccine Technologies, By Age Group
- Market Vaccine Technologies, By Distribution Channel
- Market Vaccine Technologies, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Global Health Concerns and Pandemics
- Restraints
- Regulatory Challenges
- Opportunities
- Increasing License Agreement among Key Market Players
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Vaccine Technologies Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Vaccine Technologies Market, By Technology, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Live-attenuated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Inactivated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Subunit vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Toxoid vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Viral vector vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Messenger RNA (mRNA) vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Vaccine Technologies Market, By Disease Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Non-Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Vaccine Technologies Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Vaccine Technologies Market, By Age Group, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Vaccine Technologies Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Public Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Private Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
10. Global Vaccine Technologies Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution , 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Pfizer-BioNTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Moderna
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novavax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GSK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sinovac Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dynavax Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CureVac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Valneva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
샘플 요청 목록